Results 31 to 40 of about 114,439,094 (292)
Optimising percutaneous valve-in-valve TAVI with bioprosthetic valve fracture
Percutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable patients, for high, intermediate and low surgical-risk patients over 65 years old with severe aortic valve stenosis (AS).1,2 Valve-in-valve (ViV)
Paul TL Chiam +3 more
doaj +1 more source
Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias +6 more
core +1 more source
Transcatheter Mitral Valve-in-Valve Implantations Using Inverted J-Valve
BackgroundAs bioprosthetic valves are being widely used, the incidence of structural valve deterioration increases, as well as the need for reoperation. Transcatheter mitral valve-in-valve implantations are being increasingly adopted as an alternative to
Lulu Liu +3 more
doaj +1 more source
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R +26 more
core +1 more source
BackgroundLong-term mortality risk is seldom re-assessed in contemporary clinical practice following successful transcatheter aortic valve implantation (TAVR).
Thomas Meredith +25 more
doaj +1 more source
Valves and Valve Gearing [PDF]
n ...
openaire +1 more source
Transseptal Mitral Valve-in-Valve-in-Valve
[Figure: see text]
Blanaid Canavan +6 more
openaire +3 more sources
Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves.
Luis Augusto P. Dallan +11 more
doaj +1 more source
ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak +5 more
wiley +1 more source
A Valve Design Methodology For Improved Reciprocating Compressor Performance [PDF]
The current work directly relates valve dynamics to the compressor energy efficiency. Majority of the previous studies have focused on reducing pressure losses due to valve geometry, towards improved compressor performance.
Angadi, Shruti +4 more
core +1 more source

